RESUMO
Puberty marks the end of childhood and is a period when individuals undergo physiological and psychological changes to achieve sexual maturation and fertility. The hypothalamic-pituitary-gonadal axis controls puberty and reproduction and is tightly regulated by a complex network of excitatory and inhibitory factors. This axis is active in the embryonic and early postnatal stages of life and is subsequently restrained during childhood, and its reactivation culminates in puberty initiation. The mechanisms underlying this reactivation are not completely known. The age of puberty onset varies between individuals and the timing of puberty initiation is associated with several health outcomes in adult life. In this Series paper, we discuss pubertal markers, epidemiological trends of puberty initiation over time, and the mechanisms whereby genetic, metabolic, and other factors control secretion of gonadotropin-releasing hormone to determine initiation of puberty.
Assuntos
Sistema Hipotálamo-Hipofisário/fisiologia , Sistema Hipófise-Suprarrenal/fisiologia , Puberdade , Adolescente , Criança , Feminino , Transtornos Gonadais/fisiopatologia , Hormônio Liberador de Gonadotropina/metabolismo , Humanos , Kisspeptinas/fisiologia , Masculino , Proteínas de Ligação a RNA/fisiologia , Ribonucleoproteínas/fisiologia , Maturidade Sexual , Taquicininas/fisiologia , Ubiquitina-Proteína LigasesRESUMO
Gonadal dysfunction is a complication following stem cell transplantation (SCT). There have been no reports of gonadal function in stem-cell-transplanted thalassemic survivors who received a reduced intensity conditioning regimen (RIC). We evaluated gonadal function in 47 ß-thalassemic patients following SCT with either myeloablative or reduced intensity regimen. Thirty-six patients received a myeloablative regimen, the remaining 11 patients had an RIC regimen. Their median (range) age was 13.2 (5.9-25.8) years. There were 29 patients (62%) with gonadal dysfunction (26 with primary gonadal dysfunction and three with gonadotropin deficiency). Comparisons between patients who received myeloablative and RIC regimens, revealed no differences in gonadal dysfunction (56% vs. 82%, p=0.113, respectively). In conclusion, our study demonstrated high frequency of gonadal dysfunction in these patients. Even after receiving RIC, gonadal dysfunction was very common. To our knowledge, this study is the first to report gonadal function in children and adolescents with ß-thalassemia disease who were pre-transplanted with RIC.
Assuntos
Transtornos Gonadais/etiologia , Gônadas/fisiopatologia , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Desenvolvimento Sexual , Condicionamento Pré-Transplante/efeitos adversos , Talassemia beta/terapia , Adolescente , Desenvolvimento do Adolescente/efeitos dos fármacos , Adulto , Criança , Desenvolvimento Infantil/efeitos dos fármacos , Estudos Transversais , Feminino , Transtornos Gonadais/induzido quimicamente , Transtornos Gonadais/epidemiologia , Transtornos Gonadais/fisiopatologia , Gonadotropinas/deficiência , Gônadas/efeitos dos fármacos , Hospitais Universitários , Humanos , Masculino , Agonistas Mieloablativos/efeitos adversos , Fatores de Risco , Desenvolvimento Sexual/efeitos dos fármacos , Tailândia/epidemiologia , Adulto JovemRESUMO
Since the 1980s, hematopoietic stem cell transplantation (HSCT) has been performed for malignant and non-malignant disorders leading to increasing numbers of long-term survivors. Some of them develop long-term posttransplantation complications, among them endocrine complications that arise many years after HSCT and demand to be treated till the end of patients´ life. In the paper "classical", observed several years after HSCT had been used as a treatment procedure, endocrine complications are discussed and the review of literature regarding this problem is presented. Thyroid dysfunction, disorders of somatic and sexual development are presented in details. Gonad dysfunction with the problem of fertility disturbances is reported. The paper presents the etiopathogenesis, methods of prevention, as well as treatment and the results of the treatment of these endocrine complications after HSCT. Moreover actual recommendations for screening and prevention of endocrine complications in long-term HCT survivors are presented.
Assuntos
Transtornos Gonadais/etiologia , Transtornos do Crescimento/etiologia , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Doenças da Glândula Tireoide/etiologia , Adolescente , Criança , Pré-Escolar , Doenças do Sistema Endócrino/etiologia , Transtornos Gonadais/fisiopatologia , Transtornos Gonadais/prevenção & controle , Transtornos do Crescimento/fisiopatologia , Transtornos do Crescimento/prevenção & controle , Humanos , Hipogonadismo/etiologia , Hipogonadismo/prevenção & controle , Hipoparatireoidismo/etiologia , Hipoparatireoidismo/prevenção & controle , Hipotireoidismo/etiologia , Hipotireoidismo/prevenção & controle , Masculino , Doenças da Glândula Tireoide/fisiopatologia , Doenças da Glândula Tireoide/prevenção & controle , Condicionamento Pré-Transplante/efeitos adversosRESUMO
Autoimmune polyendocrine syndromes (APS) are rare endocrinopathies characterized by the coexistence of at least two glandular autoimmune diseases. APS comprise a wide spectrum of autoimmune disorders and are divided into a very rare juvenile (APS type 1) and a more common adult type with (APS 2) or without adrenal failure (APS 3). The first clinical manifestations of APS 1 usually occur in childhood whereas APS 2 mostly occurs during the third and fourth decades of life. The third type has been described in adults that, contrary to types 1 and 2, does not involve the adrenal cortex. No clinical differences between types 2 and 3 have been described except the absence of adrenal failure. Type 4 APS is a rare syndrome characterized by the combination of autoimmune conditions not falling into the above categories. It consists of adrenal failure with one or more minor autoimmune disorders barring major components of type 1 and 2 APS. Usually, autoimmune polyendocrine syndrome of adults manifests itself as one of the major autoimmune diseases (such as adrenal failure, Grave's disease, or type 1 diabetes) and minor autoimmune disorders (vitiligo, alopecia) preceding the development of autoimmune deficiency of major endocrine glands. This article describes a patient with type 3 APS, who developed type 1 diabetes. Grave's disease and vitiligo. The development of the syndrome started from vitiligo in the chidhood. Moreover, the patient suffered primary sterility and presented with progressive diabetic nephropathy of autoimmune origin. It is concluded that patients with a single autoimmune component of polyendocrine syndrome should be screened to exclude other autoimmune endocrine disorders.
Assuntos
Diabetes Mellitus Tipo 1/etiologia , Transtornos Gonadais/etiologia , Poliendocrinopatias Autoimunes , Tireotoxicose/etiologia , Vitiligo/etiologia , Adulto , Diabetes Mellitus Tipo 1/tratamento farmacológico , Diabetes Mellitus Tipo 1/fisiopatologia , Nefropatias Diabéticas/diagnóstico , Nefropatias Diabéticas/fisiopatologia , Retinopatia Diabética/diagnóstico , Retinopatia Diabética/fisiopatologia , Transtornos Gonadais/fisiopatologia , Terapia de Reposição Hormonal/métodos , Humanos , Hipoglicemiantes/administração & dosagem , Masculino , Monitorização Fisiológica , Poliendocrinopatias Autoimunes/complicações , Poliendocrinopatias Autoimunes/diagnóstico , Poliendocrinopatias Autoimunes/terapia , Indução de Remissão , Hormônios Tireóideos/administração & dosagem , Tireoidectomia/métodos , Tireotoxicose/fisiopatologia , Tireotoxicose/cirurgiaRESUMO
BACKGROUND: We characterized the spectrum and etiology of hypogonadism in a cohort of Prader-Willi syndrome (PWS) adolescents and adults. METHODS: Reproductive hormonal profiles and physical examination were performed on 19 males and 16 females ages 16-34 years with PWS. Gonadotropins, sex-steroids, inhibin B (INB) and anti-Mullerian hormone (AMH) were measured. We defined 4 groups according to the relative contribution of central and gonadal dysfunction based on FSH and INB levels: Group A: primary hypogonadism (FSH >15 IU/l and undetectable INB (<10 pg/ml); Group B: central hypogonadism (FSH <0.5 IU/l, INB <10 pg/ml); Group C: partial gonadal & central dysfunction (FSH 1.5-15 IU/l, INB >20 pg/ml); Group D: mild central and severe gonadal dysfunction (FSH 1.5-15 IU/l, INB < 10 pg/ml. RESULTS: There were 10, 8, 9 and 8 individuals in Groups A-D respectively; significantly more males in group A (9, 4, 4 and 2; P = 0.04). Significant differences between the groups were found in mean testosterone (P = 0.04), AMH (P = 0.003) and pubic hair (P = 0.04) in males and mean LH (P = 0.003) and breast development (P = 0.04) in females. Mean age, height, weight, BMI and the distribution of genetic subtypes were similar within the groups. CONCLUSIONS: Analysis of FSH and inhibin B revealed four distinct phenotypes ranging from primary gonadal to central hypogonadism. Primary gonadal dysfunction was common, while severe gonadotropin deficiency was rare. Longitudinal studies are needed to verify whether the individual phenotypes are consistent.
Assuntos
Hormônio Foliculoestimulante/metabolismo , Transtornos Gonadais/etiologia , Inibinas/metabolismo , Síndrome de Prader-Willi/complicações , Adolescente , Adulto , Hormônio Antimülleriano/sangue , Hormônio Antimülleriano/metabolismo , Estudos de Coortes , Feminino , Hormônio Foliculoestimulante/sangue , Hormônio Foliculoestimulante/fisiologia , Transtornos Gonadais/epidemiologia , Transtornos Gonadais/fisiopatologia , Gônadas/fisiopatologia , Humanos , Hipogonadismo/sangue , Hipogonadismo/epidemiologia , Hipogonadismo/etiologia , Hipogonadismo/fisiopatologia , Individualidade , Inibinas/sangue , Inibinas/fisiologia , Masculino , Fenótipo , Síndrome de Prader-Willi/epidemiologia , Síndrome de Prader-Willi/metabolismo , Síndrome de Prader-Willi/fisiopatologia , Puberdade/sangue , Puberdade/metabolismo , Puberdade/fisiologia , Transdução de Sinais/fisiologia , Adulto JovemRESUMO
CONTEXT: Anorexia nervosa is a primary psychiatric disorder with serious endocrine consequences, including dysregulation of the gonadal, adrenal, and GH axes, and severe bone loss. This Update reviews recent advances in the understanding of the endocrine dysregulation observed in this state of chronic starvation, as well as the mechanisms underlying the disease itself. EVIDENCE ACQUISITION: Findings of this update are based on a PubMed search and the author's knowledge of this field. EVIDENCE SYNTHESIS: Recent studies have provided insights into the mechanisms underlying endocrine dysregulation in states of chronic starvation as well as the etiology of anorexia nervosa itself. This includes a more complex understanding of the pathophysiologic bases of hypogonadism, hypercortisolemia, GH resistance, appetite regulation, and bone loss. Nevertheless, the etiology of the disease remains largely unknown, and effective therapies for the endocrine complications and for the disease itself are lacking. CONCLUSIONS: Despite significant progress in the field, further research is needed to elucidate the mechanisms underlying the development of anorexia nervosa and its endocrine complications. Such investigations promise to yield important advances in the therapeutic approach to this disease as well as to the understanding of the regulation of endocrine function, skeletal biology, and appetite regulation.
Assuntos
Anorexia Nervosa/complicações , Doenças do Sistema Endócrino/etiologia , Adulto , Anorexia Nervosa/etiologia , Anorexia Nervosa/fisiopatologia , Anorexia Nervosa/terapia , Apetite/fisiologia , Regulação do Apetite , Doenças Ósseas/etiologia , Doenças do Sistema Endócrino/fisiopatologia , Feminino , Transtornos Gonadais/etiologia , Transtornos Gonadais/fisiopatologia , Hormônio do Crescimento Humano/fisiologia , Humanos , Sistema Hipotálamo-Hipofisário/fisiopatologia , Pessoa de Meia-Idade , Neurotransmissores/fisiologia , Sistema Hipófise-Suprarrenal/fisiopatologia , Recuperação de Função Fisiológica , Recompensa , Aumento de Peso/fisiologiaRESUMO
BACKGROUND: It is difficult to predict the reproductive capacity of children given hematopoietic cell transplantation (HCT) before pubertal age because the plasma concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are not informative and no spermogram can be done. METHODS: We classified the gonadal function of 38 boys and 34 girls given HCT during childhood who had reached pubertal age according to their pubertal development and FSH and LH and compared this to their plasma inhibin B and anti-Müllerian hormone (AMH). RESULTS: Ten (26%) boys had normal testicular function, 16 (42%) had isolated tubular failure and 12 (32%) also had Leydig cell failure. All 16 boys given melphalan had tubular failure. AMH were normal in 25 patients and decreased in 6, all of whom had increased FSH and low inhibin B.Seven (21%) girls had normal ovarian function, 11 (32%) had partial and 16 (47%) complete ovarian failure. 7/8 girls given busulfan had increased FSH and LH and 7/8 had low inhibin B. AMH indicated that ovarian function was impaired in all girls.FSH and inhibin B were negatively correlated in boys (P < 0.0001) and girls (P = 0.0006). Neither the age at HCT nor the interval between HCT and evaluation influenced gonadal function. CONCLUSION: The concordance between FSH and inhibin B suggests that inhibin B may help in counselling at pubertal age. In boys, AMH were difficult to use as they normally decrease when testosterone increases at puberty. In girls, low AMH suggest that there is major loss of primordial follicles.
Assuntos
Hormônio Antimülleriano/sangue , Transtornos Gonadais/diagnóstico , Transtornos Gonadais/etiologia , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Inibinas/sangue , Condicionamento Pré-Transplante/efeitos adversos , Adolescente , Biomarcadores/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Transtornos Gonadais/sangue , Transtornos Gonadais/fisiopatologia , Humanos , Hormônio Luteinizante/sangue , Masculino , Ovário/fisiopatologia , Estudos Retrospectivos , Testículo/fisiopatologiaRESUMO
The most significant corporal change observed in adolescent girls is the onset of menstruation, which occurs between 12 and 13 years of age. In several cases, described with the term 'precocious puberty', pubertal development can begin at a significantly younger age. The term 'delayed puberty' refers to absence of pubertal development in a girl over the age of 14. Amenorrhoea can occur due to a broad spectrum of causes, such as anatomic deficiencies of the reproductive tract and hormonal disorders. Hypogonadotrophic hypogonadism, which implies a permanent malfunction in gonadotrophin secretion; hypergonadotrophic hypogonadism, which involves poor ovarian response in gonadotrophin stimulation; and hyperprolactinaemia can also lead to amenorrhoea. Significant amount of stress on the adolescent girl can cause hypothalamic dysfunction, leading to a situation called 'hypothalamic amenorrhoea'. Abnormal uterine bleeding (AUB), and especially the subtype of dysfunctional uterine bleeding (DUB), is the most urgent gynaecological problem during adolescence, while dysmenorrhoea (also referred to as painful menstruation) is the most frequent problem for which adolescents and their parents refer to a physician.
Assuntos
Transtornos Gonadais/fisiopatologia , Distúrbios Menstruais/fisiopatologia , Puberdade/fisiologia , Adolescente , Criança , Feminino , Humanos , Sistema Hipotálamo-Hipofisário/fisiologia , Doenças da Hipófise/fisiopatologiaRESUMO
We conducted a prospective, multicenter investigation of human-leukocyte antigen (HLA) identical sibling bone marrow transplantation (BMT) in children with severe sickle cell disease (SCD) between 1991 and 2000. To determine if children were protected from complications of SCD after successful BMT, we extended our initial study of BMT for SCD to conduct assessments of the central nervous system (CNS) and of pulmonary function 2 or more years after transplantation. In addition, the impact on gonadal function was studied. After BMT, patients with stroke who had stable engraftment of donor cells experienced no subsequent stroke events after BMT, and brain magnetic resonance imaging (MRI) exams demonstrated stable or improved appearance. However, 2 patients with graft rejection had a second stroke after BMT. After transplantation, most patients also had unchanged or improved pulmonary function. Among the 11 patients who had restrictive lung changes at baseline, 5 were improved and 6 had persistent restrictive disease after BMT. Of the 2 patients who had obstructive changes at baseline, 1 improved and 1 had worsened obstructive disease after BMT. There was, however, significant gonadal toxicity after BMT, particularly among female recipients. In summary, individuals who had stable donor engraftment did not experience sickle-related complications after BMT, and were protected from progressive CNS and pulmonary disease.
Assuntos
Anemia Falciforme/terapia , Transplante de Medula Óssea/efeitos adversos , Doenças do Sistema Nervoso Central/etiologia , Transtornos Gonadais/etiologia , Nível de Saúde , Pneumopatias Obstrutivas/etiologia , Adolescente , Anemia Falciforme/complicações , Anemia Falciforme/fisiopatologia , Doenças do Sistema Nervoso Central/fisiopatologia , Criança , Seleção do Doador , Feminino , Seguimentos , Transtornos Gonadais/fisiopatologia , Sobrevivência de Enxerto , Doença Enxerto-Hospedeiro/tratamento farmacológico , Doença Enxerto-Hospedeiro/etiologia , Doença Enxerto-Hospedeiro/mortalidade , Antígenos HLA/imunologia , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Teste de Histocompatibilidade , Humanos , Pneumopatias Obstrutivas/fisiopatologia , Masculino , Irmãos , Análise de Sobrevida , Quimeras de Transplante , Resultado do TratamentoRESUMO
Male patients diagnosed with cancer are often referred for semen cryopreservation before gonadotoxic treatment but often have low semen quality. The aim of this study was to evaluate which type of cancer affects gonadal function and proposes a risk factor for low pre-treatment semen quality. Between January 1983 and August 2006, 764 male cancer patients were referred for semen cryopreservation prior to chemotherapy and radiotherapy. We compared semen characteristics and reproductive hormones between different groups of cancer patients. In addition, we evaluated the role of tumour markers in patients with testicular germ-cell tumours (TGCT) on fertility. Abnormal semen parameters were found in 489 men (64%) before cancer treatment. Patients with TGCT and extragonadal germ-cell tumours had significantly lower sperm concentrations and inhibin B levels than all other patient groups. No semen could be banked in 93 patients (12.2%). Eight hundred and thirty-nine of 927 (90%) produced semen samples were adequate for cryopreservation. Inhibin B in all groups showed to be the best predictor of semen quality. Although pre-treatment raised tumour markers were associated with a decrease in inhibin B and increased follicle stimulating hormone, both predictive for low semen quality; no direct linear association could be found between raised beta-HCG, alfa-fetoprotein and semen quality. Only 1/3 of cancer patients had normal semen parameters prior to cancer treatment. Patients with TGCT and extragonadal GCT have the highest risk for impaired semen quality and gonadal dysfunction at the time of semen cryopreservation.
Assuntos
Neoplasias Embrionárias de Células Germinativas/complicações , Neoplasias/complicações , Neoplasias/tratamento farmacológico , Neoplasias Testiculares/patologia , Neoplasias Testiculares/fisiopatologia , Adolescente , Adulto , Criopreservação , Fertilidade , Transtornos Gonadais/complicações , Transtornos Gonadais/patologia , Transtornos Gonadais/fisiopatologia , Humanos , Infertilidade/complicações , Infertilidade/patologia , Infertilidade/fisiopatologia , Inibinas , Masculino , Pessoa de Meia-Idade , Neoplasias/patologia , Neoplasias Embrionárias de Células Germinativas/patologia , Neoplasias Embrionárias de Células Germinativas/fisiopatologia , Oligospermia/etiologia , Oligospermia/patologia , Oligospermia/fisiopatologia , Sêmen , Análise do Sêmen , Contagem de Espermatozoides , Neoplasias Testiculares/tratamento farmacológico , Adulto JovemRESUMO
A disfunção do eixo gonadotrófico é frequentemente observada em pacientes infectados pelo HIV. A patogênese é multifatorial e está relacionada à duração da infecção pelo HIV, aos efeitos citopáticos diretos do vírus, ao uso de drogas gonadotóxicas, às infecções oportunistas, às neoplasias, à desnutrição, entre outros fatores. Em homens, a redução dos níveis de testosterona está associada à perda de massa e de força muscular, à redução da densidade mineral óssea, à lipodistrofia, à depressão, à astenia, à fadiga e à disfunção sexual. Em pacientes infectados pelo HIV com hipogonadismo, inúmeros estudos têm comprovado os efeitos benéficos da reposição de testosterona sobre o perfil metabólico e a distribuição da gordura corporal, com aumento da massa corporal magra, além de promover melhora da qualidade de vida, reduzir a perda de massa óssea e reduzir os índices de depressão. Assim, esta revisão teve como objetivo trazer uma breve atualização sobre o presente tema, abordando dados epidemiológicos, mecanismos fisiopatológicos e estratégias terapêuticas para as principais anormalidades do eixo gonadotrófico masculino associadas à infecção pelo HIV e ao seu tratamento.
Gonadotrophic axis dysfunction is commonly observed in HIV-infected patients. The pathogenesis is multifactorial and related to duration of HIV infection, direct cytopathic effects of viruses, use of drugs, opportunistic infections, malignancies, and malnutrition, among other factors. In men, reduced levels of testosterone is associated with loss of muscle mass and strength, decreased bone mineral density, lipodystrophy, depression, asthenia, fatigue and sexual dysfunction. In HIV-infected patients with hypogonadism, numerous studies have shown the beneficial effects of testosterone replacement on the metabolic profile and distribution of body fat, with increased body mass weight, and promote better quality of life, reduce the bone mass loss and the rates of depression. Thus, this review aimed to present a brief update of epidemiologic data, pathophysiology aspects and treatment strategies for the major abnormalities of male gonadotrophic axis associated with HIV infection and its treatment.
Assuntos
Humanos , Masculino , Transtornos Gonadais/etiologia , Infecções por HIV/complicações , Androgênios/uso terapêutico , Transtornos Gonadais/tratamento farmacológico , Transtornos Gonadais/fisiopatologia , Ginecomastia/etiologia , Infecções por HIV/fisiopatologia , Infecções por HIV/terapia , Síndrome de Lipodistrofia Associada ao HIV/complicações , Hiperprolactinemia/etiologia , Hipogonadismo/tratamento farmacológico , Hipogonadismo/etiologia , Testosterona/uso terapêuticoRESUMO
The onset of puberty marks a time of rapid linear growth, sexual development, and transition from childhood to maturity. The diagnosis and treatment of a childhood malignancy prior to the onset of puberty has the potential to profoundly affect the timing and the tempo of puberty. CNS tumors located in the hypothalamic-pituitary (H-P) region, surgical resection in this location, and exposure to CNS radiotherapy are all associated with both precocious and delayed puberty. Also, chemotherapy and radiation can directly damage the gonads, which can result in absent, arrested, or delayed puberty. As a consequence of these alterations of pubertal timing, both male and female survivors of childhood cancer may be at risk of adult short-stature, decreased bone-mineral density, absent or incomplete sexual development, and ultimately, reduced rates of fertility. Appropriate and timely assessment of survivors at high risk of alterations in pubertal development will enable the identification of patients who would benefit from early medical intervention.
Assuntos
Transtornos Gonadais/etiologia , Neoplasias/radioterapia , Puberdade/fisiologia , Radioterapia/efeitos adversos , Adolescente , Sistema Nervoso Central/fisiopatologia , Sistema Nervoso Central/efeitos da radiação , Criança , Irradiação Craniana/efeitos adversos , Transtornos Gonadais/fisiopatologia , Humanos , Puberdade/efeitos da radiação , Fatores de TempoRESUMO
This paper is a literature review of puberty in certain chronic diseases. Abnormal puberty is often reported in children suffering from many chronic diseases, for example: asthma, cystic fibrosis, type 1 diabetes mellitus, inflammatory diseases, children with visual and hearing impairment, and others. Delay in the onset and progression through puberty have a deleterious effect on the normal pubertal growth spurt and contribute to the deficit in final adult height. Malnutrition, toxic substances, side effects of chronic therapy, emotional deprivation and stress are the most important mechanisms responsible for delayed puberty. Delayed puberty and growth failure frequently complicate the clinical course of this children. However, few studies confirm earlier puberty in children with sense organ impairment than in healthy children. The more severe the impairment of the sense organ, the earlier was the age at puberty--the earliest age at menarche was observed in deaf girls and blind girls. The earlier age of puberty may be the outcome of therapies applied during the treatments such as radiation of the central nervous system or surgeries. Further studies are needed to determine how growth and puberty in children with chronic illness are affected by clinical practice.
Assuntos
Doença Crônica/epidemiologia , Transtornos Gonadais/epidemiologia , Transtornos Gonadais/fisiopatologia , Puberdade , Idade de Início , Asma/epidemiologia , Asma/fisiopatologia , Asma/terapia , Criança , Comorbidade , Fibrose Cística/epidemiologia , Fibrose Cística/fisiopatologia , Fibrose Cística/terapia , Diabetes Mellitus Tipo 1/epidemiologia , Diabetes Mellitus Tipo 1/fisiopatologia , Diabetes Mellitus Tipo 1/terapia , Progressão da Doença , Feminino , Transtornos da Audição/epidemiologia , Transtornos da Audição/fisiopatologia , Transtornos da Audição/terapia , Humanos , Inflamação/epidemiologia , Inflamação/fisiopatologia , Inflamação/terapia , Masculino , Resultado do Tratamento , Transtornos da Visão/epidemiologia , Transtornos da Visão/fisiopatologia , Transtornos da Visão/terapiaRESUMO
Gonadotrophic axis dysfunction is commonly observed in HIV-infected patients. The pathogenesis is multifactorial and related to duration of HIV infection, direct cytopathic effects of viruses, use of drugs, opportunistic infections, malignancies, and malnutrition, among other factors. In men, reduced levels of testosterone is associated with loss of muscle mass and strength, decreased bone mineral density, lipodystrophy, depression, asthenia, fatigue and sexual dysfunction. In HIV-infected patients with hypogonadism, numerous studies have shown the beneficial effects of testosterone replacement on the metabolic profile and distribution of body fat, with increased body mass weight, and promote better quality of life, reduce the bone mass loss and the rates of depression. Thus, this review aimed to present a brief update of epidemiologic data, pathophysiology aspects and treatment strategies for the major abnormalities of male gonadotrophic axis associated with HIV infection and its treatment.
Assuntos
Transtornos Gonadais/etiologia , Infecções por HIV/complicações , Androgênios/uso terapêutico , Transtornos Gonadais/tratamento farmacológico , Transtornos Gonadais/fisiopatologia , Ginecomastia/etiologia , Infecções por HIV/fisiopatologia , Infecções por HIV/terapia , Síndrome de Lipodistrofia Associada ao HIV/complicações , Humanos , Hiperprolactinemia/etiologia , Hipogonadismo/tratamento farmacológico , Hipogonadismo/etiologia , Masculino , Testosterona/uso terapêuticoRESUMO
Chronic stress represents a prolonged state of dyshomeostasis caused by intense and frequently imposed stressors. Obesity constitutes a chronic dysmetabolic state, leading progressively to a spectrum of metabolic complications, such as diabetes, dyslipidemia, hypertension and cardiovascular disease. Alpha growing body of evidence supports the existence of significant interactions between stress and obesity, with chronic stress promoting weight gain, and consequently excessive fat accumulation especially visceral, all these factors contributing to the development of a chronic stressful state. Maintaining body homeostasis is a prerequisite for normal reproductive function, which is vital for the survival of the species and an important process of natural selection. Under chronic stress, reproductive function is suspended and disrupted due to central and peripheral actions of hormones, adipokines and pro-inflammatory cytokines that inhibit the activity of the hypothalamic-pituitary gonadal (HPG) axis at various levels. Clinical and experimental data link both obesity and chronic stress to dysregulation of the gonadal axis, via independent and synergistic mechanisms, which may chronically lead to reproductive dysfunction and reduced fertility.
Assuntos
Transtornos Gonadais/etiologia , Obesidade/etiologia , Estresse Fisiológico/fisiologia , Doença Crônica , Transtornos Gonadais/fisiopatologia , Humanos , Sistema Hipotálamo-Hipofisário/fisiopatologia , Gordura Intra-Abdominal/patologia , Modelos Biológicos , Obesidade/patologia , Obesidade/fisiopatologia , Sistema Hipófise-Suprarrenal/fisiopatologia , Fatores de TempoAssuntos
Eletromiografia/métodos , Sistema Endócrino/fisiopatologia , Glucocorticoides/efeitos adversos , Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos , Doenças Musculares/diagnóstico , Acromegalia/complicações , Acromegalia/fisiopatologia , Nanismo Hipofisário/complicações , Nanismo Hipofisário/fisiopatologia , Seguimentos , Transtornos Gonadais/complicações , Transtornos Gonadais/fisiopatologia , Humanos , Doenças Musculares/induzido quimicamente , Doenças Musculares/etiologia , Doenças da Glândula Tireoide/complicações , Doenças da Glândula Tireoide/fisiopatologiaAssuntos
Síndrome do Cromossomo X Frágil/fisiopatologia , Transtornos Gonadais/genética , Transtornos Gonadais/fisiopatologia , Repetições de Trinucleotídeos/genética , Feminino , Síndrome do Cromossomo X Frágil/diagnóstico , Síndrome do Cromossomo X Frágil/genética , Instabilidade Genômica/fisiologia , Transtornos Gonadais/diagnóstico , Gônadas , Humanos , MasculinoRESUMO
Anti-Müllerian hormone (AMH), also called MUllerian inhibiting substance (MIS) is a product of supporting gonadal Sertoli and granulosa cells. Its main physiological role is the induction of regression of Müllerian ducts in male fetuses but it also plays a role in Leydig cell steroidogenesis and in follicular development. It is a member of the transforming growth factor B family and signals through two serine/threonine kinase receptors, only one of whom, type II, is specific. Type I receptors and the intracytoplasmic signaling molecules are shared with the bone morphogenetic family. AMH is positively regulated by SF1, SOX9 and FSH. Testosterone is a powerful downregulator. Males lacking functional AMH or AMH receptor genes do not undergo regression of MUllerian derivatives during fetal life. AMH is an excellent marker of prepubertal testicular function and has gained recognition as a valuable marker of follicular reserve in adult women.
Assuntos
Glicoproteínas/genética , Glicoproteínas/fisiologia , Transtornos Gonadais/diagnóstico , Hormônios Testiculares/genética , Hormônios Testiculares/fisiologia , Testículo/embriologia , Testículo/fisiologia , Animais , Hormônio Antimülleriano , Biomarcadores , Criança , Feminino , Transtornos Gonadais/genética , Transtornos Gonadais/fisiopatologia , Humanos , Masculino , Diferenciação Sexual/genéticaRESUMO
The polycystic ovary syndrome (PCOS) in women belongs to the most frequent endocrinopathies. This syndrome is characteristic by a hormonal and metabolic imbalance. It seems to be a kind of an oligogenic disease resulting from the interaction among several key genes and environmental effects. Considering the genetic basis of this syndrome there is no reason why the syndrome could not occur in men as well, be it with a different symptomatic expression. Premature baldness before the age of thirty used to be suggested as a symptom of the male PCOS equivalent. Yet there still seems to be rather a meagre attention devoted to the endocrinological changes in men in the specialised literature, although there do exist genealogical studies on the occurrence of alopecia or glucose metabolic disorder in male members of the families where a considerable number of females were affected by PCOS.